korrents

On the map

Tap a claim on the ring to put it at the centre.

← Biotech R&D efficiency and pharma R&D efficiency are not the same thing and should not be conflated.

17 connected korrents · 16 moments from 15 Jul 2021 to 25 Oct 2026.

Everything filed under creativity creativity Everything filed under innovation innovation Everything filed under LLMs LLMs Everything filed under design design Everything filed under protein structure prediction protein structure prediction Everything filed under AI and science AI and science Everything filed under infrastructure infrastructure Everything filed under startups startups Same subjectSame subjectSame subjectSame subjectSame subjectSame subjectSame subjectSame subjectSame subjectSame subjectSame subjectSame subjectSame subjectSame subjectSame subjectSame subjectSame subject Read this korrent: Biotech R&D efficiency and pharma R&D efficiency are not the same thing and should not be conflated. Biotech R&D efficiency and pharma R&Defficiency are not the same thing andshould not be conflated. Last stated 7 months ago 12 Apr 2026 EH Elliot Hershberg — holds since 2026-04-12 — tap for who they are Same subject: Drug discovery has become less efficient over time despite continued technological progress. — tap to centre the map on it Drug discovery has become lessefficient over time despitecontinued technological progress. Last stated 10 months ago 18 Jan 2026 EH Elliot Hershberg — holds since 2026-01-18 — tap for who they are Same subject: New technologies can meaningfully improve R&D productivity in drug development. — tap to centre the map on it New technologies can meaningfullyimprove R&D productivity in drugdevelopment. Last stated 7 months ago 12 Apr 2026 EH Elliot Hershberg — holds since 2026-04-12 — tap for who they are Same subject: AI infrastructure companies that sell tools rather than drugs can become massive, highly valuable businesses in biotech. — tap to centre the map on it AI infrastructure companies thatsell tools rather than drugs canbecome massive, highly valuablebusinesses in biotech. Last stated 12 months ago 23 Nov 2025 EH Elliot Hershberg — holds since 2025-11-23 — tap for who they are Same subject: The amount spent on R&D should not be assumed to be a useful measure of its output. — tap to centre the map on it The amount spent on R&D should notbe assumed to be a useful measure ofits output. Last stated 3 years ago 21 Feb 2024 PC Patrick Collison — holds since 2024-02-21 — tap for who they are Same subject: Pharmaceutical R&D productivity has fallen for decades: far more money spent per drug, with no matching improvement in the odds a candidate reaches the market. — tap to centre the map on it Pharmaceutical R&D productivity hasfallen for decades: far more moneyspent per drug, with no matchingimprovement in the odds a candidatereaches the market. Last stated 4 months ago 21 Jul 2026 AT Alex Telford — holds since 2023-12-23 — tap for who they are RT Ruxandra Teslo — holds since 2026-07-21 — tap for who they are Same subject: Better drug candidates do not shorten clinical trials, because a trial's duration is set by operational and regulatory friction rather than by how good the drug is. — tap to centre the map on it Better drug candidates do notshorten clinical trials, because atrial's duration is set byoperational and regulatory frictionrather than by how good the drug is. Last stated 9 months ago 28 Feb 2026 RT Ruxandra Teslo — holds since 2026-02-28 — tap for who they are Same subject: Many biotech companies have no factual basis and exist mainly to raise money to pay salaries. — tap to centre the map on it Many biotech companies have nofactual basis and exist mainly toraise money to pay salaries. Last stated 4 weeks ago 25 Oct 2026 VP Vinay Prasad — holds since 2026-10-25 — tap for who they are Same subject: The biopharma industry is structured to focus on only a limited number of disease areas. — tap to centre the map on it The biopharma industry is structuredto focus on only a limited number ofdisease areas. Last stated 2 years ago 20 May 2025 EG Elad Gil — holds since 2025-05-20 — tap for who they are Same subject: A narrow, highly accurate model can beat a general one inside its own domain, as AlphaFold did, and materials science and chip design are next. — tap to centre the map on it A narrow, highly accurate model canbeat a general one inside its owndomain, as AlphaFold did, andmaterials science and chip designare next. Last stated 4 months ago 30 Jul 2026 JD Jeff Dean — holds since 2026-07-30 — tap for who they are Same subject: Contemporary physical and evolutionary structure-prediction approaches fall far short of experimental accuracy without a close experimental homologue, limiting biological utility. — tap to centre the map on it Contemporary physical andevolutionary structure-predictionapproaches fall far short ofexperimental accuracy without aclose experimental homologue,limiting biological utility. Last stated 5 years ago 15 Jul 2021 DH Demis Hassabis — holds since 2021-07-15 — tap for who they are Same subject: Deep learning has effectively solved the problem of predicting a protein's 3D structure from its sequence. — tap to centre the map on it Deep learning has effectively solvedthe problem of predicting aprotein's 3D structure from itssequence. Last stated a year ago 29 Jun 2025 EH Elliot Hershberg — holds since 2025-06-29 — tap for who they are Same subject: A contest between five paid firms is not the way to get good creative work. — tap to centre the map on it A contest between five paid firms isnot the way to get good creativework. Last stated 3 months ago 14 Aug 2026 SK Susan Kare — holds since 2026-08-14 — tap for who they are Same subject: A culture that is uncompromising but also kind and supportive is the most fertile ground for creativity. — tap to centre the map on it A culture that is uncompromising butalso kind and supportive is the mostfertile ground for creativity. Last stated 7 months ago 12 Apr 2026 ES Evan Spiegel — holds since 2026-04-12 — tap for who they are Same subject: A feeling of responsibility is probably the greatest inhibitor of creativity; great ideas came from people not paid to have them — tap to centre the map on it A feeling of responsibility isprobably the greatest inhibitor ofcreativity; great ideas came frompeople not paid to have them IA Isaac Asimov — holds since c. 1959 — tap for who they are Same subject: "Return on tokens" has the same measurement problems as hours and capacity: it still hinges on a theory of value. — tap to centre the map on it "Return on tokens" has the samemeasurement problems as hours andcapacity: it still hinges on atheory of value. Last stated 3 months ago 17 Aug 2026 JC John Cutler — holds since 2026-08-17 — tap for who they are Same subject: A badly written AI outbound email is evidence of a bad vendor, not of a limit of AI. — tap to centre the map on it A badly written AI outbound email isevidence of a bad vendor, not of alimit of AI. Last stated 11 months ago 1 Jan 2026 JL Jason Lemkin — holds since 2026-01-01 — tap for who they are Same subject: A base model is essentially a very expensive autocomplete that continues text according to the statistics of its training documents. — tap to centre the map on it A base model is essentially a veryexpensive autocomplete thatcontinues text according to thestatistics of its trainingdocuments. Last stated 2 years ago 5 Feb 2025 AK Andrej Karpathy — holds since 2025-02-05 — tap for who they are
same subject or similar wordinga cloud: claims about one subject, named for itbar: when it was last stated, on a scale from 2015 to today — full is todaya face: someone who holds the claim — tap it for who they are

At the centre Biotech R&D efficiency and pharma R&D efficiency are not the same thing and should not be conflated. Last stated 12 Apr 2026 · 7 months ago Holds Elliot Hershberg Read this korrent →